Sanofi’s global restructuring and downsizing is now fully underway, with layoffs stretching to the company’s Belgian offices.
Sanofi to overhaul US operations of vaccines, cut jobs
GM Biosciences Announces Refocusing of Sanofi Collaboration
A settlement between Eli Lilly and insulin users has collapsed after a federal judge’s ruling that denied class certification for the lawsuit.
New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis Data support frexalimab as a potential first-in-class, high-efficacy, non-lymphocyte depleting...
Eli Lilly`s nationwide insulin pricing settlement called off
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement...
The pharmaceutical industry has experienced a notable uptick in licensing agreements for innovator drugs incorporating clustered regularly interspaced short palindromic repeats (CRISPR)-based technology over the past five years.
Ablynx NV`s Cablivi (caplacizumab) Receives Suppl Approval in the U.S.
Sanofi to divest cancer biotech it bought for $1B, axe 100 staffers in California